177 related articles for article (PubMed ID: 34289801)
1. Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study.
Kilonzo SB; Gunda DW; Majinge DC; Jaka H; Manyiri PM; Kalokola F; Mtui G; Shao ER; Bakshi FA; Stephano A
BMC Infect Dis; 2021 Jul; 21(1):699. PubMed ID: 34289801
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania.
Kawambwa RH; Majigo MV; Mohamed AA; Matee MI
BMC Public Health; 2020 Feb; 20(1):177. PubMed ID: 32019536
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania.
Telatela SP; Matee MI; Munubhi EK
BMC Public Health; 2007 Nov; 7():338. PubMed ID: 18031586
[TBL] [Abstract][Full Text] [Related]
4. DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.
Zhang JY; Li ZB; Zhang L; Wang J; Huang LP; Zhan GL; Li Z; Du J; Zhao M
BMC Infect Dis; 2019 Sep; 19(1):774. PubMed ID: 31488064
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B and C: Seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia.
Demsiss W; Seid A; Fiseha T
PLoS One; 2018; 13(5):e0196539. PubMed ID: 29763447
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C in a Mobile Low-Threshold Methadone Program.
Silva MJ; Pereira C; Loureiro R; Balsa C; Lopes P; Água-Doce I; Belo E; Martins HC; Coutinho R; Pádua E
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):657-662. PubMed ID: 28151750
[TBL] [Abstract][Full Text] [Related]
7. Sexual behaviors and seroprevalence of HIV, HBV, and HCV among hill tribe youths of Northern Thailand.
Apidechkul T
BMC Public Health; 2019 Aug; 19(1):1101. PubMed ID: 31412838
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
[TBL] [Abstract][Full Text] [Related]
9. High sero-prevalence of hepatitis B virus and human immunodeficiency virus infections among pregnant women attending antenatal clinic at Temeke municipal health facilities, Dar es Salaam, Tanzania: a cross sectional study.
Manyahi J; Msigwa Y; Mhimbira F; Majigo M
BMC Pregnancy Childbirth; 2017 Apr; 17(1):109. PubMed ID: 28388879
[TBL] [Abstract][Full Text] [Related]
10. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of HBV, HCV, and HIV and Associated Risk Factors Among Apparently Healthy Pregnant Women in Anyigba, Nigeria.
Omatola CA; Lawal C; Omosayin DO; Okolo MO; Adaji DM; Mofolorunsho CK; Bello KE
Viral Immunol; 2019 May; 32(4):186-191. PubMed ID: 31021251
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
13. Community seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in gojjam zones, northwest Ethiopia.
Abera B; Adem Y; Yimer M; Mulu W; Zenebe Y; Mekonnen Z
Virol J; 2017 Feb; 14(1):21. PubMed ID: 28166829
[TBL] [Abstract][Full Text] [Related]
14. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria.
Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM
J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972
[TBL] [Abstract][Full Text] [Related]
15. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of hepatitis B virus among HIV-positive patients at Kilimanjaro Christian Medical Centre Referral Hospital, Northern Tanzania.
Kamenya T; Damian DJ; Ngocho JS; Philemon RN; Mahande MJ; Msuya SE
Pan Afr Med J; 2017; 28():275. PubMed ID: 29881515
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania.
Matee MI; Magesa PM; Lyamuya EF
BMC Public Health; 2006 Jan; 6():21. PubMed ID: 16445860
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis B and C viruses among women of childbearing age in Moshi Urban, Tanzania.
Msuya SE; Mbizvo EM; Hussain A; Sam NE; Stray-Pedersen B
East Afr Med J; 2006 Feb; 83(2):91-4. PubMed ID: 16708880
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
